Health News Releases

June 29, 2023 11:40

AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health

AstraZeneca has announced a $400 million investment in its global AZ Forest programme, raising its commitment to plant 200 million trees by 2030 and ensure their long-term survival. This includes new

June 29, 2023 09:55

Microba Commences Phase I Clinical Trial for IBD Therapeutic

Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) today announces that the first participants have been successfully dosed in the Phase I Clinical Trial of MAP 315, in Microba’s Th

June 29, 2023 09:15

Aktana Announces New CEO

Aktana, the leader in intelligent customer engagement for the global life sciences industry, welcomes John Vitalie as Chief Executive Officer. Before joining Aktana, John led global teams across va

June 28, 2023 16:22

WCD 2023: Galderma to Present Extensive Data Demonstrating Enduring Commitment to Delivering Innovative Solutions in Dermatology

Galderma will be presenting 59 abstracts/posters from across its extensive portfolio at the 25th World Congress of Dermatology (WCD), reflecting its unrelenting dedication to delivering innovative sol

June 28, 2023 10:20

Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals

Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Environmental, Social, and Governance (ESG) Report. The report highlights the company’s progres

June 27, 2023 10:15

Galderma Raises Approximately USD 1 Billion for Newly Issued Shares in a Private Placement Round

Galderma, the emerging pure-play dermatology category leader, announced today a private placement of approximately USD 1 billion for newly issued shares, from a group consisting of current shareholder

June 27, 2023 09:55

Vertex Ventures HC Announces $200 Million Fund III to Drive Innovation in Healthcare

Vertex Ventures HC (VVHC), a women-led global healthcare investment firm, is excited to announce the launch of its third and largest fund of $200 million. Fund III will be deployed to support and empo

June 26, 2023 09:00

Pivotal Phase 3 Data Presented at ISTH 2023 Congress Spotlight TAK-755 Prophylaxis for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Takeda (TSE: 4502/NYSE:TAK) today presented favorable interim results from a global pivotal Phase 3 randomized, controlled, open-label, crossover trial evaluating the safety and efficacy of TAK-755 (r

June 25, 2023 13:26

Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)1

Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) today announced additional data demonstrating superior efficacy with survodutide (also known as BI 456906) versus placebo in people with over

June 25, 2023 13:20

Artilysin® - A Groundbreaking “Green Pharma” Solution

Lysando, the leading pioneer in the field of antimicrobial proteins has achieved significant milestones with its cutting-edge Artilysin® technology. This innovative platform has demonstrated a distinc

June 25, 2023 10:56

Jardiance® recommended for the treatment of adults with chronic kidney disease in the EU

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with

June 25, 2023 10:32

IPS Strengthens Asia and Pacific Presence with New Managing Director, Matthew Shippey

IPS, a leading provider of architecture, engineering, procurement, construction management, and validation services, announces the appointment of an industry-leading professional, Matthew Shippey, to

June 23, 2023 11:15

Brainlab and the AO Foundation Collaborate on the Future of Immersive Medical Education and Training

Brainlab, a digital medical technology company, announced today an expanded collaboration outlining initiatives in their ongoing work with the AO Foundation. Signed at the annual AO Trustees Meeting—h

June 23, 2023 10:41

Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients

Masimo (NASDAQ: MASI) today announced that Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1™ advanced health tracking watch. Masimo W1, whic

June 22, 2023 14:25

Ferring Pharmaceuticals appoints new Executive Chairman among key changes to Board of Directors

Ferring Pharmaceuticals announced today that Jean-Frédéric Paulsen has been appointed Executive Chairman of the Ferring Group, as it enters a new phase of growth following the approval of two innovati

June 22, 2023 10:55

Ferrer Initiates its ADOREXT Extension Study in Amyotrophic Lateral Sclerosis (ALS)

The international pharmaceutical company Ferrer has announced the extension of its phase III clinical trial ADORE (ALS trial with Daily ORal Edaravone), with FNP122 in amyotrophic lateral sclerosis (A

June 21, 2023 11:30

Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting

Takeda (TSE:4502/NYSE:TAK) today announced full results from the pivotal Phase 3 ADVANCE-CIDP 1 clinical trial investigating HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyalur

June 18, 2023 14:00

Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet

Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM:HCM, HKEX:13) (HUTCHMED) today announced that results of the Phase 3 FRESCO2 study evaluating fruquintinib in patients with previous

June 16, 2023 15:55

SciMed (Asia), Life Science Sales and Service Distributing Subsidiary of PHC Holdings Corporation, Becomes Wholly Owned Subsidiary -- Acquisition Expands PHC Group’s Business Supporting Researchers and Healthcare Providers in Asia-Pacific --

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has acquired the remaining 30% stake in

June 16, 2023 15:00

Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency

Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM: HCM, HKEX: 13) (HUTCHMED) today announced that the European Medicines Agency (EMA) has validated and accepted for regulatory review

June 16, 2023 14:16

Ferring Pharmaceuticals successfully increases its second Swiss Franc Bond offering by CHF 80 million

Ad hoc announcement pursuant to Art. 53 LR Ferring Pharmaceuticals announced the successful increase of its second Swiss Franc Bond offering by CHF 80 million. This senior unsecured bond transactio

June 15, 2023 15:38

First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies

With immunotherapy emerging as one of the most important treatment options in oncology, GE HealthCare has today announced the first patient scanned in a Phase I clinical trial[2] of a first-of-its kin

June 14, 2023 14:30

Sound Vaccine Secures KRW 180,000,000,000 Capital Commitment from GEM as Company Seeks to Get Uplisted on KOSDAQ

Sound Vaccine, Inc., (“Sound Vaccine”), a leading manufacturer of advanced hearing medical systems and patented hearing healthcare products, is pleased to announce that it has signed an agreement (“Ag

June 14, 2023 10:40

ZAP Surgical Announces Upcoming Installation of Novel Non-Invasive Brain Tumor Treatment System in South Korea

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Dankook University Hospital (DKUH) in Cheonan, South Korea, is slated to install the novel ZAP-X

June 13, 2023 15:43

Thales Helps Lunit Accelerate the Growth of AI-based Software Cancer Diagnostic Solutions

Thales, a global leader in Software Monetization and Licensing, is collaborating with Lunit, a global provider of AI-powered cancer diagnostics and therapeutics solutions, to help accelerate the profi

News by Region

News by Industry